ProfileGDS4132 / 227019_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 32% 29% 50% 24% 24% 33% 24% 43% 30% 43% 44% 40% 34% 51% 48% 36% 53% 42% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10176.74331
GSM201543Muscle PCOS pioglitazone 12171.323132
GSM201544Muscle PCOS pioglitazone 16174.287329
GSM201545Muscle PCOS pioglitazone 201140.81850
GSM201829Muscle PCOS pioglitazone 23159.864924
GSM201830Muscle PCOS pioglitazon 25156.095424
GSM201831Muscle PCOS pioglitazone 27181.781233
GSM201832Muscle PCOS pioglitazone 3158.344924
GSM201833Muscle PCOS pioglitazone 41104.12143
GSM201834Muscle PCOS pioglitazone 8172.457630
GSM201835Muscle PCOS after pioglitazone 10297.708543
GSM201836Muscle PCOS after pioglitazone 122103.66644
GSM201837Muscle PCOS after pioglitazone 16286.547840
GSM201838Muscle PCOS after pioglitazone 20277.067934
GSM201839Muscle PCOS after pioglitazone 232127.99951
GSM201840Muscle PCOS after pioglitazone 252124.29148
GSM201841Muscle PCOS after pioglitazone 27275.22236
GSM201842Muscle PCOS after pioglitazone 32121.19953
GSM201843Muscle PCOS after pioglitazone 42106.41642
GSM201844Muscle PCOS after pioglitazone 8298.701740